Development of pteridin-7(8H)-one analogues as highly potent cyclin-dependent kinase 4/6 inhibitors: Synthesis, structure-activity relationship, and biological activity-Reference-Cited by-同舟云学术

Development of pteridin-7(8H)-one analogues as highly potent cyclin-dependent kinase 4/6 inhibitors: Synthesis, structure-activity relationship, and biological activity

Published:2021-11 Issue: Volume:116 Page:105324
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Li Qiu,Chen Lin,Ma Yu-Feng,Jian Xie-Er,Ji Jia-Hao,You Wen-Wei,Zhao Pei-Liang

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference25 articles.

1. Cell cycle, CDKs and cancer: a changing paradigm;Malumbres;Nat. Rev. Cancer,2009

2. Advances in cyclin-dependentkinase inhibitors for the treatment of melanoma;Julve;Expert Opin. Pharmacother.,2021

3. A comprehensive insight on the recent development of cyclic dependent kinaseinhibitors as anticancer agents;Marak;Eur. J. Med. Chem.,2020

4. Recent development of CDK inhibitors: An overview of CDK/inhibitor co-crystal structures;Cheng;Eur. J. Med. Chem.,2019

5. CDK1 is sufficient to drive the mammalian cell cycle;Santamaria;Nature,2007

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the promise of pyrimidine-modified CDK inhibitors in cancer treatment;Bioorganic Chemistry;2024-08

2. Benzimidazole‐oxindole hybrids: A novel class of selective dual CDK2 and GSK‐3β inhibitors of potent anticancer activity;Archiv der Pharmazie;2024-07-23

3. The anticancer therapeutic potential of pyrimidine–sulfonamide hybrids;Future Medicinal Chemistry;2024-04-16

4. Design of balanced dual-target inhibitors of EGFR and microtubule;Bioorganic Chemistry;2024-02

5. Design, synthesis and biological evaluation of rhein–piperazine–furanone hybrids as potential anticancer agents;RSC Medicinal Chemistry;2024